{"cik":1623715,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"Imago BioSciences, Inc.","units":{"USD":[{"end":"2020-12-31","val":5105000,"accn":"0000950170-21-001529","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-19"},{"end":"2020-12-31","val":5105000,"accn":"0000950170-21-004137","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-10"},{"end":"2020-12-31","val":5105000,"accn":"0000950170-22-004569","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-24","frame":"CY2020Q4I"},{"end":"2021-06-30","val":6395000,"accn":"0000950170-21-001529","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-19","frame":"CY2021Q2I"},{"end":"2021-09-30","val":8911000,"accn":"0000950170-21-004137","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-10","frame":"CY2021Q3I"},{"end":"2021-12-31","val":10092000,"accn":"0000950170-22-004569","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-24"},{"end":"2021-12-31","val":10092000,"accn":"0000950170-22-009736","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-12"},{"end":"2021-12-31","val":10092000,"accn":"0000950170-22-017134","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-12"},{"end":"2021-12-31","val":10092000,"accn":"0000950170-22-023883","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-09","frame":"CY2021Q4I"},{"end":"2022-03-31","val":12934000,"accn":"0000950170-22-009736","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-12","frame":"CY2022Q1I"},{"end":"2022-06-30","val":8773000,"accn":"0000950170-22-017134","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-12","frame":"CY2022Q2I"},{"end":"2022-09-30","val":13838000,"accn":"0000950170-22-023883","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-09","frame":"CY2022Q3I"}]}}